TY - JOUR
T1 - 019 Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis (StarMS)
JO - Journal of Neurology Neurosurgery & Psychiatry
PY - 2022/05/27
AU - Sharrack B
AU - Snowden J
AU - Muraro P
ED -
DO - DOI: 10.1136/jnnp-2022-abn.58
VL - 93
IS - 6
SP - a19.2
EP - a1a19
Y2 - 2025/07/26
ER -